Change Healthcare (NASDAQ:CHNG) Inc. CHNG reported third-quarter fiscal 2022 adjusted earnings per share (EPS) of 36 cents, which matched the Zacks Consensus Estimate. The bottom line improved 5.9% on a year-over-year basis.
Net loss per share was 8 cents in the quarter, against the year-ago quarter’s net income of a penny.
Revenue Details
Revenues rose 10.3% from the prior-year period to $866.1 million in the reported quarter. The top line outpaced the Zacks Consensus Estimate by 1.6%.
Segmental Analysis
Change Healthcare operates through three segments — Software and Analytics, Network Solutions, Technology-Enabled Services and Postage and Eliminations.
Software and Analytics
Revenues at this segment totaled $386 million, up 3.7% on a year-over-year basis.
Network Solutions
Revenues at this segment were $226.9 million, up 17.8% year over year.
Change Healthcare Inc. Price, Consensus and EPS Surprise
Change Healthcare Inc. price-consensus-eps-surprise-chart | Change Healthcare Inc. Quote
Technology-Enabled Services
Revenues at this segment were $232.8 million, up 4.6% on a year-over-year basis.
Postage and Eliminations
Revenues at this segment totaled $20.3 million, down 7.7% year over year.
Margin Analysis
Total operating expenses were $837.4 million, up 15.9% from the prior-year quarter.
In the quarter under review, Change Healthcare reported an operating income of $28.7 million, compared with $62.7 million in the year-ago quarter.
Financial Position
The company exited the quarter with cash and cash equivalents of $96 million, compared with $80.4 million in the preceding quarter.
Cumulative net cash provided by operating activities at the end of the fiscal third quarter amounted to $438.8 million compared with $487.2 million in the year-ago period.
Guidance
Given the proposed merger agreement (with OptumInsight), Change Healthcare will not be issuing financial guidance going forward.
Wrapping Up
Change Healthcare exited the third-quarter fiscal 2022 on a mixed note, wherein earnings met the Zacks Consensus Estimate while revenues beat the same. The company exhibited robust performance across Software and Analytics, Network Solutions and Technology-Enabled segments in the quarter under review. Collaborations and expansion of Stratus Imaging PACS were the business highlights in the quarter.
However, cut-throat competition remains a headwind. Weak performance at the Postage and Eliminations segment is a woe. Higher operating expenses are concerning.
Zacks Rank
Currently, Change Healthcare carries a Zacks Rank #3 (Hold).
Key Picks
Some better-ranked stocks that are supposed to report earnings soon are Cerner Corporation (NASDAQ:CERN) CERN, Baxter International Inc (NYSE:BAX). BAX and AMN Healthcare Services (NYSE:AMN), Inc. AMN.
The Zacks Consensus Estimate for Cerner’s fourth-quarter 2021 adjusted EPS is currently pegged at 88 cents. The consensus estimate for fourth-quarter 2021 revenues stands at $1.49 billion. The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Cerner has an estimated long-term growth rate of 12.8%. CERN’s earnings yield of 4% compares favorably with the industry’s negative yield.
Baxter currently has a Zacks Rank #2. The Zacks Consensus Estimate for its fourth-quarter 2021 adjusted EPS is currently pegged at $1.03. The consensus estimate for fourth-quarter revenues stands at $3.35 billion.
Baxter has an estimated long-term growth rate of 9.5%. BAX’s earnings yield of 4.9% compares favorably with the industry’s negative yield.
AMN Healthcare currently carries a Zacks Rank #2. The Zacks Consensus Estimate for its fourth-quarter 2021 adjusted EPS currently stands at $2.58. The consensus estimate for its revenues stands at $1.28 billion.
AMN Healthcare has an estimated long-term growth rate of 16.2%. AMN’s earnings yield of 6.7% compares favorably with the industry’s 1.1%.
Just Released: Zacks Top 10 Stocks for 2022
In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?
From inception in 2012 through 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% versus the S&P 500’s +348.7%. Now our Director of Research has combed through 4,000 companies covered by the Zacks Rank and has handpicked the best 10 tickers to buy and hold. Don’t miss your chance to get in…because the sooner you do, the more upside you stand to grab.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cerner Corporation (CERN): Free Stock Analysis Report
Baxter International Inc. (BAX): Free Stock Analysis Report
AMN Healthcare Services (NASDAQ:HCSG) Inc (AMN): Free Stock Analysis Report
Change Healthcare Inc. (CHNG): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research